BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23056607)

  • 1. Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.
    Chen D; Banerjee S; Cui QC; Kong D; Sarkar FH; Dou QP
    PLoS One; 2012; 7(10):e47186. PubMed ID: 23056607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells.
    Chinnakannu K; Chen D; Li Y; Wang Z; Dou QP; Reddy GP; Sarkar FH
    J Cell Physiol; 2009 Apr; 219(1):94-9. PubMed ID: 19062173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
    Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
    Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH
    J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer.
    Singh-Gupta V; Banerjee S; Yunker CK; Rakowski JT; Joiner MC; Konski AA; Sarkar FH; Hillman GG
    Cancer Lett; 2012 May; 318(1):86-92. PubMed ID: 22155105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK).
    Draz H; Goldberg AA; Titorenko VI; Tomlinson Guns ES; Safe SH; Sanderson JT
    Cell Signal; 2017 Dec; 40():172-182. PubMed ID: 28923415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.
    Goldberg AA; Titorenko VI; Beach A; Abdelbaqi K; Safe S; Sanderson JT
    Invest New Drugs; 2014 Feb; 32(1):25-36. PubMed ID: 23709189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells.
    Akasaka Y; Hasei S; Ohata Y; Kanna M; Nakatsu Y; Sakoda H; Fujishiro M; Kushiyama A; Ono H; Matsubara A; Hinata N; Asano T; Yamamotoya T
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958994
    [No Abstract]   [Full Text] [Related]  

  • 9. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells.
    Kong D; Banerjee S; Huang W; Li Y; Wang Z; Kim HR; Sarkar FH
    Cancer Res; 2008 Mar; 68(6):1927-34. PubMed ID: 18339874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,3'-Diindolylmethane inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model.
    Cho HJ; Park SY; Kim EJ; Kim JK; Park JH
    Mol Carcinog; 2011 Feb; 50(2):100-12. PubMed ID: 21229607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.
    Beaver LM; Yu TW; Sokolowski EI; Williams DE; Dashwood RH; Ho E
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):345-51. PubMed ID: 22800507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,3'-Diindolylmethane protects against cardiac hypertrophy via 5'-adenosine monophosphate-activated protein kinase-α2.
    Zong J; Deng W; Zhou H; Bian ZY; Dai J; Yuan Y; Zhang JY; Zhang R; Zhang Y; Wu QQ; Guo HP; Li HL; Tang QZ
    PLoS One; 2013; 8(1):e53427. PubMed ID: 23326427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Rahman KM; Banerjee S; Ali S; Ahmad A; Wang Z; Kong D; Sakr WA
    Cancer Res; 2009 May; 69(10):4468-75. PubMed ID: 19435906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
    Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
    Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress.
    Chhipa RR; Wu Y; Mohler JL; Ip C
    Cell Signal; 2010 Oct; 22(10):1554-61. PubMed ID: 20570728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells.
    Abdelbaqi K; Lack N; Guns ET; Kotha L; Safe S; Sanderson JT
    Prostate; 2011 Sep; 71(13):1401-12. PubMed ID: 21321979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.
    Le HT; Schaldach CM; Firestone GL; Bjeldanes LF
    J Biol Chem; 2003 Jun; 278(23):21136-45. PubMed ID: 12665522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
    Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
    Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft model.
    Draz H; Goldberg AA; Tomlinson Guns ES; Fazli L; Safe S; Sanderson JT
    Invest New Drugs; 2018 Aug; 36(4):718-725. PubMed ID: 29607466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.